Pediatric Psychopharmacology: New Developments, Evidence, Controversies, and Role Opportunities
This INTRODUCTORY workshop will summarize recent research findings associated with pediatric psychotropic drug treatment of internalizing and externalizing disorders, FDA indications and warnings, innovative neuroimaging studies of drug effects on developing brains, ways that psychologists may help enhance treatment adherence, other new role opportunities for psychologists, and important ethical and legal considerations. Presented primarily by members of the Division 16 Task Force on Pediatric Psychopharmacology, this workshop is intended to familiarize attendees with new developments. No prior training in psychopharmacology is necessary.
Part of the APA Online Academy Convention Workshop Presentations Campus.
- Summarize recent practice and research developments, trends, issues, and controversies, including FDA warnings and indications for psychopharmacology;
- Describe potential contributions of advanced neuroimaging techniques on understanding the effects of pediatric psychopharmacology on the developing brain;
- Identify ways that psychologists in schools and related settings can contribute to improved psychopharmacological decision making and medication monitoring; and
- Identify ways that psychologists in schools and related settings can affect a family’s willingness to consider, pursue, or continue treatment.
Go to the APA Online Academy Registration Form.
If you are an APA member, please have your Membership Number available. If you don't know it, you can look up your membership number online or contact APA directly at (800) 374-2721, ext. 5580.
If you are paying by credit card, you will immediately receive an email confirmation with instructions on how to access the course and your username and password.
If you are paying by check, there is a ONE BUSINESS DAY waiting period before you can access your course. You should still register online.